<DOC>
	<DOC>NCT03042390</DOC>
	<brief_summary>This is a retrospective observational study of patients who have taken a regimen containing DRV / c at least 24 weeks prior to study initiation</brief_summary>
	<brief_title>Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice</brief_title>
	<detailed_description>The study will include 750 patients and will record data at 24 weeks. The study will also record data at 48 weeks for those patients whom these data are available</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Cobicistat</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<criteria>Patients with HIV infection Inform consent document. To have initiated therapy containing DRV / c and have a followup of at least 24 Weeks. Not having evaluable clinical data of the patient Patients not routinely followed in the center Patient less than 18 years of age.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>